ライフサイエンスコーパス: whole-body scan

1 ealthy controls (7 for brain scans and 6 for whole-body scans).

2 atient discontinued before completion of the whole-body scan.

3 -body scan followed by a posttherapy ( 131)I whole-body scan.

4 thighs were acquired immediately before each whole-body scan.

5 PET/CT scan of the pelvis and a delayed 1-h whole-body scan.

6 ere acquired immediately after the 1- to 4-h whole-body scans.

7 peak) were extracted from dynamic images and whole-body scans.

8 nd estimate the location of abnormalities in whole-body scans.

9 alizarin, mineralisation was evaluated using whole body scanning.

10 Combined with the ability to perform whole-body scanning, (18)F-FDG has revolutionized the ev

11 After an initial series of rapid whole-body scans, 3 static whole-body scans were acquire

12 at the completion of a 60-min dynamic scan, whole-body scans (4 bed positions, 5-min emission and 3-

13 Thus, 175 whole-body scans (7 per patient) were analyzed for numbe

14 ormone withdrawal using criteria of negative whole body scans (84% of euthyroid and 94% of hypothyroi

15 Whole-body scans and brain scans were obtained at variou

16 Whole-body scans and SPECT/CT studies were performed wit

17 iduals with MAS (3 for brain scans and 6 for whole-body scans) and 9 healthy controls (7 for brain sc

18 ere then followed with routine ultrasound, I whole body scan, and/or serum thyroglobulin levels for r

19 teers (3 men and 3 women) completed a single whole-body scan ( approximately 120 min, 9 time frames)

20 lood activity concentrations and the other a whole-body scan at 30 min after injection to obtain lymp

21 was performed for 60 min, followed by static whole-body scans at 1 and 2 h after injection.

22 This was followed by 3 static whole-body scans at 45, 90, and 135 min after tracer inj

23 dy composition from CT images in the limited-whole-body scan, based on thresholding of CT attenuation

24 Diagnostic whole-body scanning can be performed effectively with a

25 Whole-body scans confirmed that the brain had specific (

26 Longitudinal whole-body scans, demonstrated efficient viral uptake in

27 h patient had undergone a pretherapy ( 123)I whole-body scan followed by a posttherapy ( 131)I whole-

28 Subsequently, 4 static whole-body scans followed at 30 min, 1 h, 2 h, and 4 h a

29 er the upper abdomen; this was followed by a whole-body scan for a total of 150 min on 3 dogs.

30 60 min over the upper abdomen followed by a whole-body scan for a total of 150 min.

31 /MRI in assessing breast lesions and of FAPI whole-body scanning for lymph node (LN) and distant stag

32 ldren with leukemia and to show the value of whole-body scanning in early and delayed phases.

33 Thirty-six 131I whole-body scans (in 34 patients) showed residual uptake

34 turing the initial distribution phase in the whole-body scan; later time points showed residual (89)Z

35 ole-body imaging in conjunction with delayed whole-body scanning may enhance the diagnostic accuracy

36 offered service (n = 152, 94%), followed by whole-body scanning (n = 135, 84%), lung scanning (n = 1

37 neteen patients with complete sets of planar whole-body scans over at least 4 d and a single SPECT/CT

38 Here, we present whole body scanning PCR, a platform that relies on the l

39 Posttherapy ( 131)I whole-body scans revealed additional IAFs outside the th

40 strate two new causes of false-positive 131I whole-body scans (sebaceous cyst and cholecystitis), whi

41 Whole-body scans showed radioactivity in brain and in pe

42 ce of abnormal foci of radioiodine uptake on whole-body scanning that required subsequent treatment (

43 Four other subjects underwent whole-body scanning to estimate radiation exposure.

44 issue compartments were fit to DWI data from whole-body scans to determine optimal compartmental diff

45 udy, 5 participants (3 men) underwent serial whole-body scans to estimate organ-absorbed doses and ef

46 system acquires data simultaneously during a whole-body scan using continuous bed motion.

47 Total fat content was measured by a whole-body scan using dual-energy X-ray absorptiometry.

48 Lesion uptake was derived from the whole-body scan using various types of volumes of intere

49 Augmented whole-body scanning via magnifying PET (AWSM-PET) is a t

50 nd 4 h after injection; at visit 2, a static whole-body scan was obtained at 1 h.

51 A postablation, whole-body scan was obtained at 72 h and compared with t

52 Whole-body scanning was performed on 6 patients with hea

53 ults were compared with those of (123)I-MIBG whole-body scanning (WBS).

54 l series of rapid whole-body scans, 3 static whole-body scans were acquired at 1, 2, and 4 h after tr

55 Whole-body scans were acquired contemporaneously with a

56 nd a series of 3 rapid multiple-bed-position whole-body scans were acquired immediately afterward.

57 Between 7 and 12 sets of whole-body scans were acquired over the next 24 hr.

58 An average of 12.7 whole-body scans were acquired sequentially on a dual-he

59 An average of 20 whole-body scans were acquired sequentially on a dual-he

60 the first 30 min after injection, and static whole-body scans were obtained at 0.5, 1, 2, and 4 h aft

61 Serial whole-body scans were obtained in 9 healthy human subjec

62 n July 2001 and June 2002, 1,017 consecutive whole-body scans were obtained with a PET/CT scanner and

63 For radiation dosimetry, whole-body scans were performed at 1, 24, and 48 h and a

64 Six whole-body scans were performed over 72 h, and uptake of

65 l dosimetry in contrast to traditional I-131 whole body scan with planar imaging.

66 r 60 min after injection followed by up to 2 whole-body scans, with venous blood activity and metabol